Presumed consent: licenses and limits inferred from the case of geriatric hip fractures

Joseph Bernstein1, Drake LeBrun2, Duncan MacCourt3

  • 1University of Pennsylvania, Philadelphia, USA. Joseph.bernstein@uphs.upenn.edu.

BMC Medical Ethics
|February 26, 2017
PubMed

Insights

Presumed consent may ethically permit surgery for hip fractures in cognitively impaired elderly patients when delays in obtaining consent exceed safe treatment windows. This doctrine offers a framework for urgent geriatric care when capacity is limited.

Area of Science:

  • Geriatric Medicine
  • Medical Ethics
  • Surgical Oncology

Background:

  • Hip fractures represent a significant health challenge in the elderly population.
  • Cognitive impairment frequently complicates obtaining informed consent for surgery in geriatric patients.
  • Delayed hip fracture surgery is linked to increased mortality rates.

Purpose of the Study:

  • To explore the ethical permissibility and clinical preference for initiating surgery under presumed consent for geriatric hip fracture patients with cognitive impairment.
  • To establish an ethical framework for the application of presumed consent in such cases.

Main Methods:

  • Analysis of the ethical doctrine of presumed consent.
  • Examination of the specific clinical scenario of geriatric hip fractures.
  • Development of an ethical framework based on patient incapacity, clinical urgency, and treatment clarity.

Main Results:

  • Presumed consent requires patient incapacity, clinical urgency, and a clear course of action, all applicable to geriatric hip fractures.
  • While surgery is the consensus treatment, presumed consent should be a last resort after a safe delay window for patient stabilization and surrogate identification.

Conclusions:

  • Presumed consent is relevant when the time needed for obtaining informed consent exceeds the safe window for delaying medical intervention.
  • The doctrine is applicable when the interval for obtaining better consent is longer than the interval for safe delay of treatment.
Abstract

Related Concept Videos

Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
334
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
294
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
294
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
771
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
306